3.8 Review

The MPTP model of Parkinson's disease

Journal

MOLECULAR BRAIN RESEARCH
Volume 134, Issue 1, Pages 57-66

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.molbrainres.2004.09.017

Keywords

Parkinson's disease; glial cells; substantia nigra; MPTP

Categories

Ask authors/readers for more resources

The biochemical and cellular changes that occur following administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) are remarkably similar to that seen in idiopathic Parkinson's disease (PD). In this review, we detail the molecular activities of this compound from peripheral intoxication through its various biotransformations. In addition, we detail the interplay that occurs between the different cellular compartments (neurons and glia) that eventually consort to kill substantia nigra pars compacta (SNpe) neurons. (C) 2004 Elsevier B.V All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available